Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour
Titel:
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour
Auteur:
Wagner, Andrew J. Agulnik, Mark Heinrich, Michael C. Mahadevan, Daruka Riedel, Richard F. von Mehren, Margaret Trent, Jonathan Demetri, George D. Corless, Christopher L. Yule, Murray Lyons, John F. Oganesian, Aram Keer, Harold